{"id":55266,"date":"2023-03-28T16:06:22","date_gmt":"2023-03-28T14:06:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/"},"modified":"2023-03-28T16:06:22","modified_gmt":"2023-03-28T14:06:22","slug":"arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/","title":{"rendered":"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions"},"content":{"rendered":"<div>\n<p>\n<i>CVS will enhance its privacy statement and transparency into law enforcement data requests to address investor concerns that states with restrictive abortion laws will request sensitive customer data.<\/i>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/5\/Arjuna_Capital_Logo_CMYK-02.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/21\/Arjuna_Capital_Logo_CMYK-02.jpg\"><\/a><\/p>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;CVS has committed to enhance its data privacy disclosures and transparency reporting in response to a <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fstatic1.squarespace.com%2Fstatic%2F5bc65db67d0c9102cca54b74%2Ft%2F6421f706bf78d246f438416f%2F1679947527086%2FCVS%2BData%2BPrivacy%2BProposal%2B-%2B12222.pdf&amp;esheet=53368953&amp;newsitemid=20230328005306&amp;lan=en-US&amp;anchor=shareholder+proposal&amp;index=1&amp;md5=77c408782eb0529bfaf3cdcd09f948a7\" rel=\"nofollow noopener\" shape=\"rect\">shareholder proposal<\/a> filed by investment management firm Arjuna Capital, co-filer Presbyterian Church U.S.A. and partner Rhia Ventures. The shareholder proposal, filed in November 2022, asked CVS to address threats to privacy of customers\u2019 reproductive health data collected and maintained by the company. Following a productive dialog with investors, CVS committed to further protect reproductive health data by enhancing its privacy statement regarding how it responds to law enforcement data requests, publishing semiannual transparency reports on the number of legal information requests received, improving internal legal request tracking processes, and continuing conversations with Arjuna Capital around protecting consumers\u2019 reproductive health data. As a result, Arjuna withdrew the proposal from going to a vote at CVS\u2019s annual meeting this spring.\n<\/p>\n<p>\nArjuna filed the proposal following last June\u2019s US Supreme Court decision which ended the constitutional right to abortion protections (Dobbs v. Jackson Women\u2019s Health Organization). Investors are increasingly concerned about how companies are using the personal digital data they collect for the enforcement of state laws that ban or restrict abortion access, noting companies\u2019 business interests are at risk. Fears heightened following news in 2022 that Meta satisfied a Nebraska police warrant by turning over private Facebook messages that were used as evidence to charge a mother and daughter with felony crimes related to the alleged illegal termination of the daughter\u2019s pregnancy. Meta received significant negative press in response.\n<\/p>\n<p>\n<b>\u201cCVS is taking the steps necessary to protect its customers\u2019 privacy and data in a post-Dobbs world,\u201d<\/b> said Natasha Lamb, managing partner at Arjuna Capital. <b>\u201cIt\u2019s clear that threats to women\u2019s privacy are also a threat to CVS\u2019s business, brand, and investors.\u201d<\/b>\n<\/p>\n<p>\nRhia Ventures\u2019 Director of Corporate Engagement, Shelley Alpern, who has supported numerous investor proposals regarding reproductive rights said, <b>\u201cThe <i>Dobbs <\/i>decision has created enormous uncertainty for companies who are in possession of personal health information. Law enforcement agencies are not required to be specific or transparent regarding their information demands. Companies will have to go the extra mile to protect their customers. The outcome of Arjuna\u2019s proposal and engagement with CVS on these challenges has been very rewarding.\u201d<\/b>\n<\/p>\n<p>\nAs CVS collects sensitive commercial data through its pharmacy and sales of over-the-counter medications like Plan B, it is important the company retains customers\u2019 trust by safeguarding personal data whenever possible. Companies in possession of sensitive customer data can best protect it by scrutinizing law enforcement data requests to ensure their legality and by responding narrowly by providing only the data requested. CVS has committed to enhance its privacy statement so that it protects clients\u2019 data whenever possible. By providing transparency reporting, investors will be able to review CVS\u2019s law enforcement request trends year-over-year to better understand how customers\u2019 data might be at risk.\n<\/p>\n<p>\nArjuna Capital filed seven shareholder proposals, and other investors filed an additional 24 proposals this proxy season, addressing the business risks associated with reproductive health restrictions. These proposals focus on reproductive health data privacy, political spending, risk assessments of how state anti-abortion policies will impact companies\u2019 workforces, hospital policies, maternal health care, and health insurance companies\u2019 plan offerings regarding abortion and contraception. Arjuna\u2019s proposal at United Parcel Service (UPS) requesting a risk assessment of how state anti-abortion policies will impact the company, including employee recruitment and retention challenges, will go to a vote on May 4, 2023.\n<\/p>\n<p>\nArjuna Capital is a sustainable investment firm that works with accredited investors and institutions to invest their assets integrating Environmental, Social, and Governance (ESG) risks and opportunities. Arjuna Capital has been recognized for using shareholder resolutions to promote racial and gender pay equity in the tech, banking, and consumer sectors. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.Arjuna-Capital.com&amp;esheet=53368953&amp;newsitemid=20230328005306&amp;lan=en-US&amp;anchor=www.Arjuna-Capital.com&amp;index=2&amp;md5=c164085f59c83538e2e3aebfd930b20c\" rel=\"nofollow noopener\" shape=\"rect\">www.Arjuna-Capital.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJulia Frost, (978)866-0208, <a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#106;&#x75;&#x6c;i&#97;&#x63;&#64;&#97;&#x72;&#x6a;u&#110;&#x61;-&#99;&#x61;&#x70;&#105;&#116;&#x61;l&#46;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#117;&#x6c;i&#97;&#x40;&#x61;r&#106;&#x75;&#x6e;a&#45;&#x63;a&#112;&#x69;&#x74;a&#108;&#x2e;&#x63;o&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CVS will enhance its privacy statement and transparency into law enforcement data requests to address investor concerns that states with restrictive abortion laws will request sensitive customer data. BOSTON&#8211;(BUSINESS WIRE)&#8211;CVS has committed to enhance its data privacy disclosures and transparency reporting in response to a shareholder proposal filed by investment management firm Arjuna Capital, co-filer &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-55266","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CVS will enhance its privacy statement and transparency into law enforcement data requests to address investor concerns that states with restrictive abortion laws will request sensitive customer data. BOSTON&#8211;(BUSINESS WIRE)&#8211;CVS has committed to enhance its data privacy disclosures and transparency reporting in response to a shareholder proposal filed by investment management firm Arjuna Capital, co-filer ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-28T14:06:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/21\/Arjuna_Capital_Logo_CMYK-02.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions\",\"datePublished\":\"2023-03-28T14:06:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/\"},\"wordCount\":675,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005306\\\/en\\\/1431570\\\/21\\\/Arjuna_Capital_Logo_CMYK-02.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/\",\"name\":\"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005306\\\/en\\\/1431570\\\/21\\\/Arjuna_Capital_Logo_CMYK-02.jpg\",\"datePublished\":\"2023-03-28T14:06:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005306\\\/en\\\/1431570\\\/21\\\/Arjuna_Capital_Logo_CMYK-02.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005306\\\/en\\\/1431570\\\/21\\\/Arjuna_Capital_Logo_CMYK-02.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/","og_locale":"en_US","og_type":"article","og_title":"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions - Pharma Trend","og_description":"CVS will enhance its privacy statement and transparency into law enforcement data requests to address investor concerns that states with restrictive abortion laws will request sensitive customer data. BOSTON&#8211;(BUSINESS WIRE)&#8211;CVS has committed to enhance its data privacy disclosures and transparency reporting in response to a shareholder proposal filed by investment management firm Arjuna Capital, co-filer ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-28T14:06:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/21\/Arjuna_Capital_Logo_CMYK-02.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions","datePublished":"2023-03-28T14:06:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/"},"wordCount":675,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/21\/Arjuna_Capital_Logo_CMYK-02.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/","url":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/","name":"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/21\/Arjuna_Capital_Logo_CMYK-02.jpg","datePublished":"2023-03-28T14:06:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/21\/Arjuna_Capital_Logo_CMYK-02.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230328005306\/en\/1431570\/21\/Arjuna_Capital_Logo_CMYK-02.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arjuna-capital-cvs-commits-to-strengthen-customer-privacy-protections-amidst-reproductive-health-restrictions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Arjuna Capital: CVS Commits to Strengthen Customer Privacy Protections Amidst Reproductive Health Restrictions"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55266"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55266\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}